CBLL Stock Summary and Trading Ideas (Ceribell | NASDAQ:CBLL)

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Ceribell trades on the NASDAQ stock market under the symbol CBLL.

As of March 10, 2025, CBLL stock price declined to $22.21 with 254,544 million shares trading.

CBLL has a beta of 1.75, meaning it tends to be more sensitive to market movements. CBLL has a correlation of 0.22 to the broad based SPY ETF.

CBLL has a market cap of $796.64 million. This is considered a Small Cap stock.

Last quarter Ceribell reported $19 million in Revenue and -$.40 earnings per share. This beat revenue expectation by $984,000 and missed earnings estimates by -$.09.

The top ETF exchange traded funds that CBLL belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

CBLL support price is $21.74 and resistance is $23.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBLL shares will trade within this expected range on the day.